The transradial closure devices market is experiencing significant growth and transformation in recent years. These innovative medical devices play a crucial role in the field of interventional cardiology, as they facilitate the closure of radial artery access sites after diagnostic and therapeutic procedures. This market’s growth can be attributed to several key factors, including technological …
Category Archives: Healthcare Trends
In Vitro Fertilization Banking Services Market is likely to reach US$ 11,652.7 Million by 2033, FMI Report
The global In vitro fertilization banking services market had a net worth of US$ 4,310.9 million as of the year 2023. The global demand for in vitro fertilisation banking services is anticipated to increase until 2033 at a 10.5% annual pace, according to the FMI market study. Furthermore, it is anticipated that by the conclusion …
Cryopreservation in In-Vitro Fertilization (IVF) Market to Grow by 10.6% CAGR by 2033, Giving Infertile Couples New Hope | FMI
Cryopreservation, the process of preserving biological materials at extremely low temperatures, has revolutionized the field of in-vitro fertilization (IVF). This cutting-edge technique has opened new avenues for couples struggling with infertility, offering them hope and the possibility of starting a family. The cryopreservation for in-vitro fertilization (ivf) market has seen remarkable growth in recent years, …
Intrauterine Insemination Devices Market Set to Grow at 3.6% CAGR, Gaining Traction as First-Line Infertility Treatment in Developing Countries: FMI Report
The Intrauterine Insemination Devices Market is anticipated to be worth US$ 40.5 million in 2023 and US$ 57.5 million by 2033. Devices for intrauterine insemination are expected to be in high demand, with a 3.6% CAGR predicted. The demand for intrauterine insemination devices is being driven by the rising awareness of reproductive treatments and infertility. …
Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market is expected to rise to US$ 6.2 Billion by 2033: FMI
The Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market is expected to reach a value of US$ 3.3 billion in 2023 and US$ 6.2 billion by 2033. A CAGR of 6.6% is anticipated for the market over the forecast period. Market expansion is fueled by the escalating enzyme deficits and lysosomal storage diseases as …
Stethoscope Market to Reach US$ 1056.0 Million by 2033, Driven by Rising Respiratory and Cardiovascular Ailments | FMI
The global stethoscope market is expected to grow and reach US$ 1056.0 million by the end of 2033, up from US$ 612.9 million in 2023. It is anticipated to grow at a CAGR of 5.6% between 2023 and 2033, creating an absolute monetary potential of US$ 38.4 million. The stethoscope industry is anticipated to grow …
Global Medical Nitroglycerin Sprays Market to Grow at 3.9% CAGR, Driven by Rising Prevalence of Cardiovascular Diseases: FMI Research
As per the research conducted by FMI, the global medical nitroglycerin sprays market is expected to record a CAGR of 3.9% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 110.9 million. By 2033, the valuation is expected to reach US$ 163.5 million. The group of medications …
Instrument Cleaners & Detergents Market to reach US$ 3.2 Billion by the year 2033: to Benefit from Rising Demand for Healthcare and Food Safety | FMI
The instrument cleaners & detergents market plays a crucial role in ensuring the safety, efficiency, and longevity of various instruments used in industries such as healthcare, laboratory research, and manufacturing. This market segment encompasses a wide range of cleaning solutions designed to remove contaminants, residues, and impurities from instruments and equipment, maintaining their functionality and …
Biological and Chemical Indicators Market to Reach US$ 866.9 Million by 2033, FMI Forecasts
The Biological and Chemical Indicators Market is anticipated to increase at a CAGR of 5.9% from 2023 to 2033, reaching a value of US$ 490.3 million. The market is anticipated to reach US$ 866.9 million by 2033. The demand for biological and chemical markers is being driven by the increased focus on patient safety and …
Caprolactam Industry Expected to Reach US$21.9 Billion by 2032, Fueled by 3.9% CAGR | FMI Insights
The global caprolactam industry is poised for substantial growth, projecting a robust CAGR of 3.9% throughout the forecast period (2022 – 2032). In 2022, the market was valued at US$15.0 billion, and it’s anticipated to surge to an impressive US$21.9 billion by 2032. One of the primary drivers of this growth is the escalating demand …